Consultation: Electronic media in prescription drug labelling draft guidance document
From Health Canada
Current status: Closed
This consultation ran from March 12, 2021 to May 7, 2021.
Comments were requested on the draft guidance.
Who was the focus of this consultation
Health Canada engaged with:
- industry
- health professionals
- other interested parties
Contact us
Bureau of Policy, Science and International Programs
Therapeutic Products Directorate
Health Canada
1600 Scott Street
Holland Cross, Tower B
2nd Floor, Address Locator 3102C5
Ottawa, Ontario
K1A 0K9
E-mail: hc.policy.bureau.enquiries.sc@canada.ca